Call for Innovators: 2022 Annual Digital Therapeutics Innovation Case Collection Launched
[Click the image to register now]
In recent years, the consumption structure of the population has continued to upgrade, with health demands exhibiting multi-level, diversified, and personalized characteristics. The 14th Five-Year Plan for the Development of the Health Industry notes that a new round of technological and industrial revolutions is accelerating, and next-generation information technologies should continue to drive profound transformations in healthcare service models. New health-related business formats and models will flourish.
As an innovative and highly effective therapeutic approach, digital therapeutics focus on addressing the shortcomings of traditional medical interventions. Their precision, personalization, and intelligence deliver significant value to patients, healthcare providers, payers, and pharmaceutical and medical device companies. The deployment of digital therapeutics products has further fostered new perceptions and expectations among patients regarding disease prevention, management, and treatment.
In 2016, the exploration of digital therapeutics (DTx) in China officially commenced. Over the following six years, the DTx industry experienced robust growth, carving out a distinct path within the healthcare sector by overcoming numerous challenges, bolstered by supportive policies and favorable contemporary conditions. The outbreak of the pandemic forced patients who were unable to access normal medical care to seek necessary treatment plans through alternative channels, thereby creating new opportunities that accelerated the innovation and upgrading of the DTx industry. This period saw the emergence of a large number of DTx companies and products.
From the “5th Future Healthcare 100 Conference,” “Digital Therapeutics City Summit,” “International Digital Therapeutics Summit,” “Inaugural China Digital Therapeutics Innovation Summit,” and “China Digital Health Conference” in 2021, to this year’s “Digital Therapeutics Innovation Technology Seminar,” “Digital Therapeutics Online Salon,” and “Founding Conference of the Digital Therapeutics Professional Committee under the China Medical Devices Industry Association,” VCBeat has continuously deepened its exchanges and collaboration in the field of digital therapeutics. From last year’s “White Paper on Digital Therapeutics in China” released by VCBeat Research Institute to this year’s “Global Digital Therapeutics Industry Report,” we have directly confronted the opportunities and challenges encountered during the rise and growth of digital therapeutics in China. Through exploration and practice, we have focused on driving innovation and breakthroughs in digital therapeutics, continually identifying high-potential innovative enterprises and teams, and accompanying and witnessing China’s digital therapeutics sector as it gradually charts its own distinctive course.
Global digital therapeutics are rapidly evolving and will continue to undergo upgrades and iterations in the future. To better promote the development of digital therapeutics and the digital transformation of traditional therapies, as well as to accelerate the incubation and implementation of digital therapeutic products, VCBeat and VB100 have jointly launched the 2022 Annual Call for Innovative Cases in Digital Therapeutics, inviting all stakeholders to discover new “digital” forces!
Call for Innovative Digital Therapeutics Case Studies from Healthcare Institutions and Innovative Enterprises, with a Focus on Innovation in Disease Prevention, Disease Management, and Disease Treatment
1. Registration Period: November 23, 2022 – December 23, 2022
2. Selection Period: December 23, 2022 – December 30, 2022
VCBeat and VB100 will collaborate with industry experts to evaluate case studies of domestic healthcare institutions and innovative enterprises. Through multi-dimensional analysis and assessment covering product introduction, innovation and iterability, product safety, and application value, high-quality digital therapeutics cases will be selected.
1. Outstanding cases will be granted promotional exposure on the VCBeat official website and its media matrix;
2. The Excellent Case Award received the “2022 Annual High-Quality Innovative Cases in Digital Therapeutics” certificate issued by VCBeat;
3. Selected outstanding cases will have the opportunity to serve as benchmark examples, become priority invitees for digital therapeutics initiatives, and participate in subsequent industry activities related to digital therapeutics.
Scan the QR code below or click the link below to fill out the registration form (it is recommended to complete it on a computer).
Registration Link:https://vb100.mike-x.com/mqoSG
Teacher Ren Phone: 13108940563
Teacher Lin Phone: 15730481218